Treatment News : Previous Syphilis Infection Might Cause Poorer Brain Function for People With HIV - by David Evans

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » March 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


March 1, 2011

Previous Syphilis Infection Might Cause Poorer Brain Function for People With HIV

by David Evans

HIV-positive people who have been infected with syphilis (Treponema pallidum) in the past might have poorer brain function than HIV-positive people who have never had it. These data were presented Monday, February 28, at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.

In the past several years the dramatic early successes of combination antiretroviral (ARV) treatment for HIV—with dramatic drops in death rates and AIDS-related infection—have given way to a growing recognition that significant health complications remain even in the face of near-perfect viral control. One type of health problem that has captured researchers’ interests is damage to the network of cells that make up the brain and nervous system.

Data from a stack of research studies have confirmed that the pool of HIV in the brain is different from the HIV circulating in blood. While this is not entirely surprising—the brain is well protected from the rest of the body, and immune cells there differ somewhat from immune cells elsewhere—the implications of differing patterns of HIV reproduction are now being documented. These have included high rates of neurological damage in people with HIV. The damage in most people is so mild that it goes unrecognized, but researchers are worried that it could ultimately lead to higher rates of dementia as people get older.

Another infectious organism that can attack the brain is syphilis. In its later stages, syphilis in the brain (called neurosyphilis) can lead to a number of disconcerting symptoms, including problems with concentration, coordination and emotional disturbances. In people not infected with HIV, the course of untreated syphilis is typically quite slow; in fact, people must usually be infected for several years before neurosyphilis develops. In people with HIV, however, the disease course is more rapid, and untreated syphilis can begin affecting the brain within a matter of months.

Given the high rates of syphilis infection among people with HIV, Christina Marra, MD, from the University of Washington in Seattle grew concerned that the long-term impact of syphilis infection—even years after it was successfully treated—hadn’t been well documented in people with HIV.

To explore this further, she and her colleagues examined people enrolled in a larger study of HIV, ARVs and neurocognitive function called the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study. Out of a total of 1,574 people enrolled in CHARTER, Marra’s team found 82 people who had positive rapid plasma reagin (RPR) test of their rectums, indicating that they had a history of syphilis. These people were matched to 52 similar HIV-positive people who had no history of syphilis infection.

Roughly three quarters of the participants were male, just over half were black, and 65 percent were taking ARV therapy. The average age of the participants was 41, and most had completed high school. Thirty-one of the 84 participants with a history of syphilis were found to have recent, untreated infection.

Marra and her colleagues found that a history of syphilis, both recent and past, resulted in lower neuropsychological performance based on two types of test. This was true even when they ruled out differences in reading skill and education. There was no difference in neuropsychological function between people recently infected (and untreated) and those who had syphilis in the past and who had been successfully treated.

The authors caution that further studies following people over time are needed to confirm these results and to determine the long-term impact, but they state that the results indicate that good syphilis screening programs are a necessity in HIV care and that people with a history of syphilis may need to have their cognitive function monitored more closely over time.

Search: Syphilis, Treponema pallidum, neuropsychological, neurological, neurosyphilis, cognitive function, Christina Marra, CHARTER

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.